R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Authors: Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W PLoS ONE, 2015;10(5):e0127518. Species: Human Sample Type: Serum
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1. Authors: Ambaglio I, Malcovati L, Papaemmanuil E, Laarakkers C, Della Porta M, Galli A, Da Via M, Bono E, Ubezio M, Travaglino E, Albertini R, Campbell P, Swinkels D, Cazzola M Haematologica, 2013;98(3):420-3. Species: Human Sample Type: Serum
Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression. Authors: Cheng JC, Chang HM, Leung PC Endocrinology, 2011;152(8):2987-95. Species: Human Sample Type: Cell Culture Supernates
Plasma markers for identifying patients with metastatic melanoma. Authors: Kluger HM, Hoyt K, Bacchiocchi A, Mayer T, Kirsch J, Kluger Y, Sznol M, Ariyan S, Molinaro A, Halaban R Clin. Cancer Res., 2011;17(8):2417-25. Species: Human Sample Type: Plasma
GDF-15 contributes to proliferation and immune escape of malignant gliomas. Authors: Roth P, Junker M, Tritschler I, Mittelbronn M, Dombrowski Y, Breit SN, Tabatabai G, Wick W, Weller M, Wischhusen J Clin. Cancer Res., 2010;16(15):3851-9. Species: Human Sample Type: Serum
Macrophage inhibitory cytokine-1 regulates melanoma vascular development. Authors: Huh SJ, Chung CY, Sharma A Am. J. Pathol., 2010;176(6):2948-57. Species: Human Sample Type: Serum
Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Authors: Forejtnikova H, Vieillevoye M, Zermati Y, Lambert M, Pellegrino RM, Guihard S, Gaudry M, Camaschella C, Lacombe C, Roetto A, Mayeux P, Verdier F Blood, 2010;116(24):5357-67. Species: Human Sample Type: Cell Culture Supernates
Progressive postnatal motoneuron loss in mice lacking GDF-15. Authors: Strelau J, Strzelczyk A, Rusu P, Bendner G, Wiese S, Diella F, Altick AL, von Bartheld CS, Klein R, Sendtner M, Unsicker K J. Neurosci., 2009;29(43):13640-8. Species: Human Sample Type: Cell Culture Supernates
Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency. Authors: Finkenstedt A, Bianchi P, Theurl I, Vogel W, Witcher DR, Wroblewski VJ, Murphy AT, Zanella A, Zoller H Br. J. Haematol., 2009;144(5):789-93. Species: Human Sample Type: Serum
Regulation of growth differentiation factor 15 expression by intracellular iron. Authors: Lakhal S, Talbot NP, Crosby A, Stoepker C, Townsend AR, Robbins PA, Pugh CW, Ratcliffe PJ, Mole DR Blood, 2009;113(7):1555-63. Species: Human Sample Type: Cell Culture Supernates
Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Authors: Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P, Bing C Endocrinology, 2009;150(4):1688-96. Species: Human Sample Type: Cell Culture Supernates
Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. Authors: Ramirez JM, Schaad O, Durual S, Cossali D, Docquier M, Beris P, Descombes P, Matthes T Br. J. Haematol., 2009;144(2):251-62. Species: Human Sample Type: Serum
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Authors: Tamary H, Shalev H, Perez-Avraham G, Zoldan M, Levi I, Swinkels DW, Tanno T, Miller JL Blood, 2008;112(13):5241-4. Species: Human Sample Type: Serum
Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. Authors: Zimmermann MB, Fucharoen S, Winichagoon P, Sirankapracha P, Zeder C, Gowachirapant S, Judprasong K, Tanno T, Miller JL, Hurrell RF Am. J. Clin. Nutr., 2008;88(4):1026-31. Species: Human Sample Type: Serum
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. Authors: Barbarotto E, Corallini F, Rimondi E, Fadda R, Mischiati C, Grill V, Vaccarezza M, Celeghini C J. Cell. Biochem., 2008;104(2):595-605. Species: Human Sample Type: Cell Culture Supernates
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway. Authors: Zauli G, Rimondi E, Corallini F, Fadda R, Capitani S, Secchiero P J. Bone Miner. Res., 2007;22(10):1621-30. Species: Human Sample Type: Cell Culture Supernates
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Authors: Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH, Eling TE, Childs R, Ganz T, Leitman SF, Fucharoen S, Miller JL Nat. Med., 2007;13(9):1096-101. Species: Human Sample Type: Serum
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. Authors: Secchiero P, Corallini F, Rimondi E, Chiaruttini C, di Iasio MG, Rustighi A, Del Sal G, Zauli G Blood, 2007;111(3):1287-94. Species: Human Sample Type: Cell Culture Supernates
|